期刊文献+

非小细胞肺癌组织中PTEN、NF-κB的表达及临床意义

The expression and clinical significance of PTEN and NF-κB in NSCLC tissues
下载PDF
导出
摘要 目的检测非小细胞肺癌(NSCLC)组织中张力蛋白同源的磷酸酶基因(PTEN)和核因子κB(NF-κB)的表达及其与临床病理特征及预后的关系。方法运用免疫组织化学法检测PTEN、NF-κB在肺癌组织以及癌旁正常肺组织中的表达情况。结果 PTEN蛋白在肺癌组织中的阳性表达率明显低于癌旁正常肺组织(P<0.05);而NF-κB蛋白在肺癌中的阳性表达率,明显高于癌旁正常肺组织(P<0.05)。PTEN、NF-κB的阳性表达率与临床病理分期、组织分化程度及术后生存期有关(P<0.05),而与性别、年龄、吸烟史、肿瘤大小及病理类型无关(P>0.05);临床病理分期低、组织分化好的患者生存时间较长,差异有统计学意义(P<0.05)。此外,肺癌中PTEN与NF-κB呈负相关(rs=-11.30,P<0.05)。结论PTEN基因的失活、NF-κB基因的活化可能促进了肺癌的发生、发展和侵袭转移的进程,可作为临床评价肿瘤恶性程度及预后的指标。 Objective To detect the expressions of phosphatase and tensin homology deleted on chromosome ten ( PTEN ) and nuclear factor-KB (NF-KB) in non-small-cell lung carcinoma (NSCLC) tissues, and to explore their correlation with clinical pathological characteristics as well as patient' s prognosis. Methods The immunochemistry method was used to detect the expressions of PTEN and NF-KB in NSCLC tissues and adjacent nontumorous tissues. Results The positive rates of PTEN expression in lung cancer tissues were 24.42% (21/ 86) ,which were significantly lower than 72.09% (62/86) in adjacent nontumorous tissues ( P 〈 0.05 ), however,the positive rates of NF-KB expression in lung cancer tissues were 63. 95% (55/83), which were significantly higher than 25.58% (22/86) in paracancerous tissues ( P 〈 0.05 ). The positive rates of PTEN and NF-KB expressions were related to clinical pathology staging, differentiation degree of tissue and survival periods after operation, however,which were not correlated with gender, age, smoking, tumor size and histological grading ( P 〉 0. 05 ) , however , the expression of PTEN was negatively correlated to that of NF-KB ( rs = -11.30, P 〈 0.05). Conclusion The inactivation of PTEN gene and activation of NF-KB gene may promote the pathogenesis, development, invasion and metastasis of lung cancer, which can be used as the indexes to evaluate tumor' s malignant degree and prognosis.
出处 《河北医药》 CAS 2013年第20期3052-3054,共3页 Hebei Medical Journal
基金 邢台市科学技术研究与发展计划项目(编号:2012ZC207)
关键词 PTEN NF-ΚB 非小细胞肺癌 PTEN NF-KB non-small-cell lung carcinoma
  • 相关文献

参考文献7

  • 1Mina S,Bohn BA,Simon R,et al. PTEN deletion is rare but often homo- geneous in gastric cancer. J Clin Pathol,2012,65:693-698.
  • 2Gallardo A, Lerma E, Escuin D, et al. Increased signalling of EGFR and IGF1R,and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas. Br J Cancer,2012, 106 : 1367-1373.
  • 3Fornari F, Milazzo M, Chieco P, et al. In hepatocellular carcinoma miR- 519d is up-regulated by p53 and DNA hypomethylation and targets CD- KN1 A/p21, PTEN, AKT3 and TIMP2. J Patho1,2012 ,227 :275-285.
  • 4MacKenzie L, McCall P, Hatziieremia S, et al. Nuclear factor kappaB pre- dicts poor outcome in patients with hormone-naive prostate cancer with high nuclear androgen receptor. Hum Pathol,2012,43 : 1491-1500.
  • 5Yang P, Guo L, Duan Z J, et al. Histone methyhransferase NSD2/MMSET mediates constitutive NF-kappaB signaling for cancer cell proliferation, survival, and tumor growth via a feed-forward loop. Mol Cell Biol, 2012, 32:3121-3131.
  • 6Lertwittayapon T,Tencomnao T, Santiyanont R. Inhibitory effect of alter- natively spliced RAGEvl on the expression of NF-KBand TNF-alpha in hepatocellular carcinoma cells. Genet Mol Res,2012,11 : 1712 -1720.
  • 7Li F, Wang Y, Wang X, et al. Ganoderic acids suppress growth and angio- genesis by modulating the NF-kappaB signaling pathway in breast cancer cells. Int J Clin Pharmacol Ther,2012 ,50 :712-721.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部